Latest Research & Analysis

29-Apr-2021 - Nike, Inc. – NKE:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using the Freedom of...

29-Apr-2021 - Schlumberger Limited – SLB: SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using the...

29-Apr-2021 - Switch, Inc. – SWCH:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using the Freedom...

29-Apr-2021 - Thomson Reuters Corporation – TRI:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in...

29-Apr-2021 - As of the date of the response in the table below, we received Freedom of Information Act (FOIA) responses from the SEC to suggest the absence of recent SEC investigative activity.  If you think any of these companies have SEC investigations, or had them in the recent past, let...

23-Apr-2021 - Company’s appearing in today’s research update -- Eagle Bancorp, Inc. – EGBN Rhythm Pharmaceuticals Inc. – RYTM Rush Enterprises, Inc. – RUSHA Territorial Bancorp, Inc. – TBNK Plus – Probes Reporter Data Feed: No Recent SEC Investigative Records Found – 78 Companies...

23-Apr-2021 - Eagle Bancorp, Inc. – EGBN:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise in using...

23-Apr-2021 - Rhythm Pharmaceuticals Inc. – RYTM:  SEC Investigation Update Probes Reporter® research provides data, commentary, and analysis on public company interactions with investors and with the SEC.   Our work is heavily reliant on company disclosures and our expertise...

Pages